Identification of a NOS2 mutation and impaired NO production in Dahl/Rapp rats provides a potential genetic and biochemical basis for their salt-sensitive hypertension.
Answers are grounded in this paper and cite their sources.
NOS2 variant may explain salt-sensitive hypertension in this rat model; leaves open relevance to human disease and requires clinical validation.
Salt-sensitive hypertension in the Dahl/Rapp rat (S strain) is prevented by L-arginine. Based on the observations that dexamethasone prevented the antihypertensive effect of L-arginine in these animals and the suggestion that a locus in or near an inducible nitric oxide synthase (NOS) gene on chromosome 10 cosegregated with hypertension in some F2 crosses that utilized the S rat, the present study explored the hypothesis that the vascular smooth muscle isoform of inducible NOS (NOS2) was abnormal in S rats. Primary cultures of aortic smooth muscle cells from S rats demonstrated impaired inducible NO production, which improved with increased L-arginine in the medium. Sequence analysis identified a single T-->C transversion that produced an amino acid substitution (S714P) between the FAD and FMN binding sites and a restriction fragment length polymorphism. This restriction fragment length polymorphism was present only in S rats. The mutation of NOS2 and the role of this enzyme in the pathogenesis of salt-sensitive hypertension in the Dahl/Rapp rat require further investigation.
No takes yet. Share an insight, caveat, or question.
Chen et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: